Jessica St. Laurent, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endometrial Neoplasms | 5 | 2023 | 1357 | 1.100 |
Why?
|
| Hydatidiform Mole | 2 | 2021 | 254 | 0.800 |
Why?
|
| Iodide Peroxidase | 1 | 2021 | 294 | 0.670 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2021 | 1173 | 0.540 |
Why?
|
| Lymphatic Metastasis | 1 | 2020 | 2943 | 0.410 |
Why?
|
| Papillomaviridae | 1 | 2018 | 1117 | 0.400 |
Why?
|
| Papillomavirus Vaccines | 1 | 2018 | 495 | 0.400 |
Why?
|
| DNA Methylation | 1 | 2023 | 4372 | 0.330 |
Why?
|
| Disease Progression | 2 | 2021 | 13505 | 0.290 |
Why?
|
| Carcinoma, Endometrioid | 2 | 2020 | 276 | 0.280 |
Why?
|
| Ovarian Neoplasms | 1 | 2023 | 4878 | 0.270 |
Why?
|
| Papillomavirus Infections | 1 | 2018 | 1607 | 0.270 |
Why?
|
| Virulence Factors | 2 | 2017 | 511 | 0.190 |
Why?
|
| Selenoproteins | 1 | 2021 | 214 | 0.170 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2023 | 633 | 0.160 |
Why?
|
| Hysterectomy | 2 | 2020 | 904 | 0.150 |
Why?
|
| Multiprotein Complexes | 1 | 2023 | 1120 | 0.140 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2017 | 1276 | 0.140 |
Why?
|
| Corneal Ulcer | 1 | 2017 | 128 | 0.130 |
Why?
|
| Ovary | 1 | 2019 | 958 | 0.120 |
Why?
|
| Pseudomonas Infections | 2 | 2017 | 623 | 0.120 |
Why?
|
| Eye Infections, Bacterial | 1 | 2017 | 239 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2020 | 1408 | 0.110 |
Why?
|
| Brachytherapy | 1 | 2020 | 1238 | 0.110 |
Why?
|
| Epoxy Compounds | 1 | 2012 | 137 | 0.100 |
Why?
|
| T-Box Domain Proteins | 1 | 2014 | 468 | 0.100 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2020 | 2007 | 0.100 |
Why?
|
| Uterine Neoplasms | 1 | 2020 | 1439 | 0.100 |
Why?
|
| Bacterial Proteins | 2 | 2017 | 3825 | 0.100 |
Why?
|
| Neoplasms, Second Primary | 1 | 2019 | 1060 | 0.100 |
Why?
|
| Radiopharmaceuticals | 1 | 2020 | 2634 | 0.090 |
Why?
|
| Wnt Proteins | 1 | 2014 | 719 | 0.090 |
Why?
|
| Neoplasms | 1 | 2018 | 22075 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2023 | 5795 | 0.080 |
Why?
|
| Female | 10 | 2023 | 391246 | 0.070 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2012 | 1130 | 0.070 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2020 | 733 | 0.060 |
Why?
|
| Breast | 1 | 2014 | 1963 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2020 | 3787 | 0.060 |
Why?
|
| Humans | 13 | 2023 | 760613 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2014 | 3663 | 0.050 |
Why?
|
| Pregnancy | 2 | 2021 | 29746 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 9278 | 0.050 |
Why?
|
| Stem Cells | 1 | 2014 | 3524 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2021 | 41337 | 0.050 |
Why?
|
| Retrospective Studies | 5 | 2020 | 80345 | 0.050 |
Why?
|
| Adult | 5 | 2021 | 220007 | 0.050 |
Why?
|
| Mutation | 2 | 2023 | 29957 | 0.040 |
Why?
|
| DNA, Bacterial | 2 | 2017 | 1456 | 0.040 |
Why?
|
| Prognosis | 1 | 2020 | 29661 | 0.040 |
Why?
|
| Disease-Free Survival | 2 | 2020 | 6831 | 0.040 |
Why?
|
| Endometrium | 1 | 2020 | 403 | 0.040 |
Why?
|
| Young Adult | 2 | 2021 | 58748 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 20509 | 0.040 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2017 | 217 | 0.040 |
Why?
|
| Adolescent | 2 | 2021 | 87809 | 0.030 |
Why?
|
| Middle Aged | 5 | 2020 | 220359 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2020 | 1791 | 0.030 |
Why?
|
| Japan | 1 | 2019 | 1369 | 0.030 |
Why?
|
| Lymph Node Excision | 1 | 2020 | 1303 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2020 | 2609 | 0.030 |
Why?
|
| Aged | 3 | 2020 | 169143 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2017 | 1006 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2020 | 3618 | 0.030 |
Why?
|
| DNA, Intergenic | 1 | 2012 | 105 | 0.020 |
Why?
|
| Chromatin | 1 | 2023 | 2938 | 0.020 |
Why?
|
| Lentivirus | 1 | 2014 | 506 | 0.020 |
Why?
|
| Operon | 1 | 2012 | 370 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2017 | 1949 | 0.020 |
Why?
|
| Progesterone | 1 | 2014 | 742 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 1837 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2014 | 2627 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2012 | 1234 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 3617 | 0.020 |
Why?
|
| Estrogens | 1 | 2014 | 1520 | 0.020 |
Why?
|
| Ligands | 1 | 2014 | 3276 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 6065 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2012 | 4169 | 0.020 |
Why?
|
| Collagen | 1 | 2014 | 2636 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2023 | 9591 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 11070 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 4716 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 11152 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 3442 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2023 | 12102 | 0.010 |
Why?
|
| Binding Sites | 1 | 2012 | 6048 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 2012 | 1274 | 0.010 |
Why?
|
| Genotype | 1 | 2017 | 12957 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 5782 | 0.010 |
Why?
|
| Protein Binding | 1 | 2012 | 9335 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2020 | 24102 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2014 | 10442 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 16932 | 0.010 |
Why?
|
| Phenotype | 1 | 2014 | 16548 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 25941 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 58980 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 23374 | 0.010 |
Why?
|
| United States | 1 | 2019 | 72448 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 81209 | 0.000 |
Why?
|
| Animals | 1 | 2014 | 167960 | 0.000 |
Why?
|
| Male | 1 | 2017 | 359718 | 0.000 |
Why?
|